share_log

Form 144 | Roivant Sciences(ROIV.US)高管拟出售68.95万股股份,价值约827.74万美元

Form 144 | Roivant Sciences(ROIV.US) Officer Proposes to Sell 8.28 Million in Common Stocks

Moomoo News ·  Dec 27, 2024 05:19

SEC FILLINGS DISCLOSED/ Dec 26, $Roivant Sciences (ROIV.US)$$ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM) (ROIVW.US)$ Officer Sukhatme Mayukh intends to sell 689.5K shares of its common stock on Dec 26, with a total market value of approximately $8.28 million.

Sukhatme Mayukh has reduced shareholding in $Roivant Sciences (ROIV.US)$$ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM) (ROIVW.US)$ by 609.33K shares since Dec 18, 2024, with a total value of approximately $7.33 million.

1735247949147046887.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment